124 related articles for article (PubMed ID: 3607576)
1. Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
Roché H; Hyman G; Nahas G; Stoopler M; Ellison R; Desjardins R
Cancer Invest; 1987; 5(2):89-93. PubMed ID: 3607576
[TBL] [Abstract][Full Text] [Related]
2. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
4. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
Pollera CF; Nardi M; Marolla P; Calabresi F
Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
6. High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study.
Giaccone G; Bertetto O; Secat MA; Calciati A
Oncology; 1988; 45(2):74-8. PubMed ID: 3353076
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
10. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
Niederle N; Schütte J; Schmidt CG
Klin Wochenschr; 1986 Apr; 64(8):362-5. PubMed ID: 3009962
[TBL] [Abstract][Full Text] [Related]
11. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
Denaro A; Rossi M; Garozzo A; Matera M; Neri V
G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
[TBL] [Abstract][Full Text] [Related]
12. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
Huys J; Troch M; Bourguignon RP; Smets P
Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
[TBL] [Abstract][Full Text] [Related]
13. A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.
Olver IN; Wolf M; Laidlaw C; Bishop JF; Cooper IA; Matthews J; Smith R; Buchanan L
Eur J Cancer; 1992; 28A(11):1798-802. PubMed ID: 1389512
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
Pollera CF; Nardi M; Marolla P; Carlini P
Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
[TBL] [Abstract][Full Text] [Related]
15. [Phase I study of alizapride in cancer patients treated with cisplatin].
Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of high-dose i.v. alizapride in prevention of cisplatin-induced emesis.
Canal P; Roche H; Pasquier M; Bugat R; Berg D; Soula G; Carton M
Fundam Clin Pharmacol; 1987; 1(3):213-7. PubMed ID: 3428840
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
Matsui K; Fukuoka M; Takada M; Kusunoki Y; Yana T; Tamura K; Yoshida T; Iida K; Hirashima T; Tsukada H; Ushijima S; Miyawaki H; Masuda N
Br J Cancer; 1996 Jan; 73(2):217-21. PubMed ID: 8546909
[TBL] [Abstract][Full Text] [Related]
18. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.
Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M
Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
Smaglia RA; Parkinson DR; Taylor CD
Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis.
Abad-Esteve A; Rosell R; Moreno I; Serichol M; Moya L; Ribas-Mundo M
Oncology; 1989; 46(4):235-7. PubMed ID: 2740066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]